Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial

ObjectivePatients receiving radionuclide 131I treatment expose radiation to others, and there was no clinical trial to verify the effectiveness and safety of mobile robots in radionuclide 131I isolation wards. The objective of this randomized clinical trial was to evaluate the effectiveness and safe...

Full description

Bibliographic Details
Main Authors: Dan Li, Dingwei Gao, Suyun Fan, GangHua Lu, Wen Jiang, Xueyu Yuan, Yanyan Jia, Ming Sun, Jianjun Liu, Zairong Gao, Zhongwei Lv
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1042604/full
_version_ 1797956921008848896
author Dan Li
Dan Li
Dingwei Gao
Dingwei Gao
Dingwei Gao
Suyun Fan
GangHua Lu
GangHua Lu
Wen Jiang
Wen Jiang
Xueyu Yuan
Xueyu Yuan
Yanyan Jia
Ming Sun
Jianjun Liu
Zairong Gao
Zhongwei Lv
Zhongwei Lv
author_facet Dan Li
Dan Li
Dingwei Gao
Dingwei Gao
Dingwei Gao
Suyun Fan
GangHua Lu
GangHua Lu
Wen Jiang
Wen Jiang
Xueyu Yuan
Xueyu Yuan
Yanyan Jia
Ming Sun
Jianjun Liu
Zairong Gao
Zhongwei Lv
Zhongwei Lv
author_sort Dan Li
collection DOAJ
description ObjectivePatients receiving radionuclide 131I treatment expose radiation to others, and there was no clinical trial to verify the effectiveness and safety of mobile robots in radionuclide 131I isolation wards. The objective of this randomized clinical trial was to evaluate the effectiveness and safety of mobile robots in providing vital signs (body temperature and blood pressure) and radiation dose rate monitoring for patients receiving radionuclide therapy.MethodsAn open-label, multicenter, paired, randomized clinical trial was performed at three medical centers in Shanghai and Wuhan, China, from 1 April 2018 to 1 September 2018. A total of 72 participants were assigned to the group in which vital signs and radiation doses were both measured by mobile robots and conventional instruments. Intergroup consistency, completion rate, and first success rate were the primary effectiveness measures, and vital sign measurement results, the error rate of use, and subjective satisfaction were secondary indicators. Adverse events related to the robot were used to assess safety.ResultsOf the 72 randomized participants (median age, 39.5; 27 [37.5%] male participants), 72 (100.0%) completed the trial. The analysis sets of full analysis set, per-protocol set, and safety analysis set included 72 cases (32 cases in Center A, 16 cases in Center B, and 24 cases in Center C). The consistency, completion rate, and first success rate were 100% (P = 1.00), and the first success rates of vital signs and radiation dose rate were 91.7% (P = 1.000), 100.0% (P = 0.120), and 100.0% (P = 1.000). There was no significant difference in vital signs and radiation dose rate measurement results between the robot measurement group and the control group (P = 0.000, 0.044, and 0.023), and subjective satisfaction in the robot measurement group was 71/72 (98.6%), compared to 67/72 (93.1%) in the control group. For safety evaluation, there was no adverse event related to the mobile robot.ConclusionThe mobile robots have good effectiveness and safety in providing vital signs and radiation dose rate measurement services for patients treated with radionuclides.
first_indexed 2024-04-10T23:56:18Z
format Article
id doaj.art-07540548512141c0af81a84acb0a0e16
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-10T23:56:18Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-07540548512141c0af81a84acb0a0e162023-01-10T12:33:57ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-01-011010.3389/fpubh.2022.10426041042604Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trialDan Li0Dan Li1Dingwei Gao2Dingwei Gao3Dingwei Gao4Suyun Fan5GangHua Lu6GangHua Lu7Wen Jiang8Wen Jiang9Xueyu Yuan10Xueyu Yuan11Yanyan Jia12Ming Sun13Jianjun Liu14Zairong Gao15Zhongwei Lv16Zhongwei Lv17Department of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaShanghai Tenth People's Hospital, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaShanghai Tenth People's Hospital, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, ChinaShanghai Tenth People's Hospital, Tongji University, Shanghai, ChinaObjectivePatients receiving radionuclide 131I treatment expose radiation to others, and there was no clinical trial to verify the effectiveness and safety of mobile robots in radionuclide 131I isolation wards. The objective of this randomized clinical trial was to evaluate the effectiveness and safety of mobile robots in providing vital signs (body temperature and blood pressure) and radiation dose rate monitoring for patients receiving radionuclide therapy.MethodsAn open-label, multicenter, paired, randomized clinical trial was performed at three medical centers in Shanghai and Wuhan, China, from 1 April 2018 to 1 September 2018. A total of 72 participants were assigned to the group in which vital signs and radiation doses were both measured by mobile robots and conventional instruments. Intergroup consistency, completion rate, and first success rate were the primary effectiveness measures, and vital sign measurement results, the error rate of use, and subjective satisfaction were secondary indicators. Adverse events related to the robot were used to assess safety.ResultsOf the 72 randomized participants (median age, 39.5; 27 [37.5%] male participants), 72 (100.0%) completed the trial. The analysis sets of full analysis set, per-protocol set, and safety analysis set included 72 cases (32 cases in Center A, 16 cases in Center B, and 24 cases in Center C). The consistency, completion rate, and first success rate were 100% (P = 1.00), and the first success rates of vital signs and radiation dose rate were 91.7% (P = 1.000), 100.0% (P = 0.120), and 100.0% (P = 1.000). There was no significant difference in vital signs and radiation dose rate measurement results between the robot measurement group and the control group (P = 0.000, 0.044, and 0.023), and subjective satisfaction in the robot measurement group was 71/72 (98.6%), compared to 67/72 (93.1%) in the control group. For safety evaluation, there was no adverse event related to the mobile robot.ConclusionThe mobile robots have good effectiveness and safety in providing vital signs and radiation dose rate measurement services for patients treated with radionuclides.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1042604/fullmobile robot131I treatmentradiation safetyvital signs and radiation dose rateeffectiveness
spellingShingle Dan Li
Dan Li
Dingwei Gao
Dingwei Gao
Dingwei Gao
Suyun Fan
GangHua Lu
GangHua Lu
Wen Jiang
Wen Jiang
Xueyu Yuan
Xueyu Yuan
Yanyan Jia
Ming Sun
Jianjun Liu
Zairong Gao
Zhongwei Lv
Zhongwei Lv
Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
Frontiers in Public Health
mobile robot
131I treatment
radiation safety
vital signs and radiation dose rate
effectiveness
title Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
title_full Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
title_fullStr Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
title_full_unstemmed Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
title_short Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial
title_sort effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving iodine 131 radiotherapy a randomized clinical trial
topic mobile robot
131I treatment
radiation safety
vital signs and radiation dose rate
effectiveness
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1042604/full
work_keys_str_mv AT danli effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT danli effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT dingweigao effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT dingweigao effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT dingweigao effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT suyunfan effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT ganghualu effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT ganghualu effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT wenjiang effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT wenjiang effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT xueyuyuan effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT xueyuyuan effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT yanyanjia effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT mingsun effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT jianjunliu effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT zaironggao effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT zhongweilv effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial
AT zhongweilv effectivenessofmobilerobotscollectingvitalsignsandradiationdoserateforpatientsreceivingiodine131radiotherapyarandomizedclinicaltrial